Double-blind, placebo-controlled randomised clinical trial to evaluate the effect of ASPIRIN discontinuation after left atrial appendage occlusion in atrial fibrillation: protocol of the ASPIRIN LAAO trial.
Mu ChenQunshan WangJian SunPeng-Pai ZhangWei LiBin-Feng MoTai-Zhong ChenXiaoli TangYi-Gang Linull nullPublished in: BMJ open (2021)
NCT03821883.
Keyphrases
- left atrial appendage
- double blind
- placebo controlled
- clinical trial
- phase iii
- phase ii
- atrial fibrillation
- low dose
- study protocol
- catheter ablation
- cardiovascular events
- antiplatelet therapy
- open label
- randomized controlled trial
- phase ii study
- oral anticoagulants
- percutaneous coronary intervention
- left atrial
- anti inflammatory drugs
- direct oral anticoagulants
- heart failure
- coronary artery disease
- acute coronary syndrome
- type diabetes
- cardiovascular disease